Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Public comment period · §3

Draft standard: determination of chromatographic purity by… — disposition

The disposition of every submission and the amendments that resulted.

Document identifier
CEI-CP-004/3
Series
Public comment period
Version
1.0
Published
30 Jun 2023
Last reviewed
30 Jun 2023
Next review
30 Jun 2024
Identifier
10.71829/cei.cp.4
Certainty
Not rated
Cycle
2023 Q2
Window
28 Apr 2023 – 28 May 2023
Status
Closed
Submissions
5

§3Disposition and amendments

§3.1Disposition table

Table 1. Every submission with its disposition. Each row links to the submission in full.

ReferenceRespondentPoint raisedDisposition
DRAFT-RP-HPLC-PURI/001Dr Liesbeth Nyquist-ObioraThe standard does not state that a determination on one unit says nothing about the batchAccepted
DRAFT-RP-HPLC-PURI/002Rukayat Zaleski-MbekiThe matrix interferes with the determination and no control is requiredAccepted
DRAFT-RP-HPLC-PURI/003Dr Liesbeth AchterbergThe standard should require documented operator competenceNot accepted
DRAFT-RP-HPLC-PURI/004Dr Jolanta UttridgeThe standard should state a pass limitNot accepted
DRAFT-RP-HPLC-PURI/005Dr Abimbola Sotomayor-EkwuemeNothing addresses the container the material was held inAccepted in part
5 submissions in total.

§3.2Summary by disposition

Table 2. Counts by disposition, with the meaning of each.

DispositionCountMeaning
Accepted2The submission is accepted and the draft is amended as proposed. The amendment is recorded in the amendment log of the document it changed and is traceable to the numbered submission.
Accepted in part1Part of the submission is accepted and part is not. The secretariat response states which part is which and on what ground the remainder was declined.
Noted, no amendment0The submission raises a point the Institute accepts but that does not require a change to the draft, most often because the draft already states it elsewhere. The location is given in the response.
Not accepted2The submission is not accepted. The secretariat response gives the reason. A submission that is not accepted remains published in full; the Institute does not remove a submission because it disagrees with it.

§3.3Resulting amendments

  1. The standard does not state that a determination on one unit says nothing about the batch — arising from DRAFT-RP-HPLC-PURI/001. Every determination made under this standard now carries a sampling statement recording how many units were sampled, from what population and by what plan, and the standard states that a determination on a single unit supports no inference about any other…
  2. The matrix interferes with the determination and no control is required — arising from DRAFT-RP-HPLC-PURI/002. An inhibition and enhancement control is now required for every determination under this standard, with stated recovery limits, and a determination reported without it is recorded as not conformant rather than as a low result.
  3. Nothing addresses the container the material was held in — arising from DRAFT-RP-HPLC-PURI/005. Container type and headspace atmosphere are now reported where known, and recorded as not held where they are not, rather than omitted.

References cited on this page

References are numbered in order of first citation in this document. Each superscript in the text links to its entry below.

  1. International Organization for Standardization. ISO/IEC 17025:2017 General Requirements for the Competence of Testing and Calibration Laboratories. ISO/IEC Standard 2017;3rd edition. identifier not held by the Institute

Identifiers are reproduced only where the Institute holds them. Where a digital object identifier or PubMed identifier is not shown, the Institute has recorded the journal and year and has not constructed an identifier.

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.